Press Releases
Press Releases
More Press Releases
View Older Stories View Newer Stories-
Q32 Bio to Participate in Oppenheimer's 35th Annual Healthcare Life Sciences Conference
-
Syndax Pharmaceuticals Reports Inducement Grants Under NASDAQ Listing Rule 5635(c)(4)
-
Neutrogena® Introduces Tate McRae as Global Brand Ambassador
-
QIAGEN receives positive court decision reaffirming an important QuantiFERON-TB patent
-
Quince Therapeutics Receives Notice of Allowance Covering Innovative Method of Use for Lead Indication Ataxia-Telangiectasia
-
Olo Announces Date of Fourth Quarter and Fiscal Year 2024 Earnings Call
-
Nuvectis Pharma Announces Proposed Public Offering of Common Stock
-
Exagen Inc. to Participate in Upcoming Investor Conferences
-
Nasdaq Reports January 2025 Volumes
-
Varonis Announces Fourth Quarter 2024 and Full-Year 2024 Financial Results
-
Medifast to Announce Financial Results for the Fourth Quarter and Full Year Ended December 31, 2024
-
ASGN Incorporated to Acquire TopBloc, A Preferred Workday Services Partner
-
Carbon Revolution Announces Receipt of Extension from Nasdaq Stock Market
-
Runway Growth Finance Corp. Announces Date for Fourth Quarter and Full Year 2024 Financial Results and Conference Call
-
InnovAge Announces Financial Results For the Fiscal Second Quarter Ended December 31, 2024
-
Dynagas LNG Partners LP Declares Cash Distribution on its Series B Preferred Units
-
Nasdaq CEO Adena Friedman to Present at the 2025 UBS Financial Services Conference
-
Intapp Announces Second Quarter Fiscal Year 2025 Financial Results
-
Golden Entertainment to Report 2024 Fourth Quarter and Full Year Results on February 27 and Host Conference Call and Webcast
-
CVRx Reports Fourth Quarter and Full Year 2024 Financial and Operating Results
-
Apellis Pharmaceuticals Announces Inducement Grants Under Nasdaq Listing Rule 5635(c)(4)
-
Latham Group, Inc. Announces Fourth Quarter and Full Year 2024 Earnings Release and Conference Call Date
-
AdaptHealth Corp. Announces Fourth Quarter and Full Year 2024 Earnings Release Date and Conference Call
-
HF Foods Group Inc. to Participate in the Oppenheimer Emerging Growth Conference
-
Ambassador David Pressman Returns to Jenner & Block
-
Omnicom Reports Fourth Quarter and Full Year 2024 Results
-
Husqvarna and Flex announce strategic partnership
-
Horizon Space Acquisition II Corp. Announces the Separate Trading of its Ordinary Shares and Rights, Commencing on February 5, 2025
-
Amdocs Limited Reports First Quarter Fiscal 2025 Results
-
NVO INVESTOR ALERT: Novo Nordisk A/S Investors with Substantial Losses Have Opportunity to Lead Investor Class Action Lawsuit
-
Gibson Energy Announces Chief Financial Officer Transition
-
Altisource Announces Proposed Distribution of Warrants to Purchase Common Stock and Sets February 14, 2025 as the Record Date For Proposed Distribution
-
AMGEN REPORTS FOURTH QUARTER AND FULL YEAR 2024 FINANCIAL RESULTS
-
Collective Mining Expands the High-Grade Ramp Zone by Intersecting 51.95 Metres at 8.38 g/t AuEq Including 18.05 Metres at 16.32 g/t AuEq
-
SunCar Technology Group Announces Follow-On Public Offering
-
Mercury Systems Reports Second Quarter Fiscal 2025 Results
-
Lumen Technologies reports fourth quarter and full year 2024 results
-
Mulvihill Premium Yield Fund Declares Monthly Fund Distribution for Its ETF Class
-
Premium Income Corporation Announces Monthly Distribution
-
Mulvihill Enhanced Split Preferred Share ETF Declares Monthly Distribution
-
Mulvihill Canadian Bank Enhanced Yield ETF Declares Monthly Distribution
-
Astec Industries, Inc. (NASDAQ: ASTE) Announces the Company’s Fourth Quarter and Full Year 2024 Conference Call on February 26, 2025, at 8:30 A.M. Eastern Time
-
Jeff Woolard Named Cirrus Logic Chief Financial Officer
-
TriLink BioTechnologies® and Aldevron Enter into Non-exclusive License and Supply Agreement for CleanCap® mRNA Capping Technology
-
Fate Therapeutics Reports New Employee Inducement Awards Under Nasdaq Listing Rule 5635(c)(4)
-
Ritani's Jewelry 411: Week of February 3
-
The Manitowoc Company Expands its Direct-to-Customer Footprint in Georgia, North Carolina, and South Carolina
-
Intellia Therapeutics Reports Inducement Grants under Nasdaq Listing Rule 5635(c)(4)
-
Premium Global Income Split Corp. Declares Monthly Distribution
-
The Woodward, Geneva's First All-Suite Hotel and Only Three-Michelin Key and Two-Michelin Star Dining Destination Joins Auberge Resorts Collection
